Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …

Introduction: Endometrial cancer is the most common gynaecological cancer and its
incidence is rising due to increasing obesity rates. We are also seeing an increasing trend of …

Purpose: To conduct a phase I clinical trial with a second-generation oncolytic herpes
simplex virus (HSV) expressing granulocyte macrophage colony-stimulating factor (Onco …

Epithelial ovarian cancer (EOC) is the leading cause of death among gynecological
malignancies worldwide. The five-year survival rates for stage IIIC and IV patients are 29 …

Genome-wide association studies (GWAS) have identified 76 variants associated with
prostate cancer risk predominantly in populations of European ancestry. To identify …

The HOX genes are a family of homeodomain-containing transcription factors that determine
cellular identity during development. Here we review a number of recent studies showing …

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in
Patients With Localized or Locally Advanced Renal Cell Carcinoma - PMC Back to Top Skip to …

Breast, ovarian, and prostate cancers are hormone-related and may have a shared genetic
basis, but this has not been investigated systematically by genome-wide association (GWA) …

Objectives To develop and validate a genetic tool to predict age of onset of aggressive
prostate cancer (PCa) and to guide decisions of who to screen and at what age. Design …

Purpose: Prostate cancer (PC) is the second most common cause of cancer related death in
men. A number of key limitations with prostate specific antigen (PSA), currently the standard …